Examination of the effect of Lactiplantibacillus plantarum 22A-3 on the liver function indicates

Not Applicable

• Conditions: o

• Registration Number: JPRN-UMIN000048757
• Lead Sponsor: CXwellness, Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-29
• Study Completion: 2022-12-07
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Not provided

Exclusion Criteria

[1] Individuals who are currently receiving drug treatment due to some kind of illness. In addition, individuals who regularly use drugs or quasi-drugs for purposes other than disease treatment. [2] Individuals who regularly use vitamins. [3] Individuals who used or applied a drug for treatment of disease in the past 1 month. [4] Individuals who have, are undergoing treatment, or have a history of serious diseases such as diabetes, kidney disease, liver disease, heart disease, thyroid disease, adrenal disease, and other metabolic diseases. [5] Individuals who contract or have a history of serious endocrine disease. [6] Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months. [7] Individuals who experienced unpleasant feeling during blood drawing. [8] Individuals who are sensitive to test product or other foods, and medical products (especially allergies to wheat). [9] Individuals with serious anemia. [10] Individuals with bleeding teeth or oral problems, such as periodontal disease or mouth ulcer. [11] Individuals who have significant changes in their physical condition due to menopause. [12] Individuals who regularly use food for specified health use, functional foods, and health foods. [13] Individuals who regularly use foods or supplements containing lactic asid bacteria and bifidobacterium. [14] Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60g/day). [15] Individuals who are smoker. [16] Individuals with possible changes of life style during the test period. [17] Individuals who habitually perform strenuous exercise such as running, marathon, soccer, etc. [18] Individuals who participated in other clinical studies in the past a month. [19] Individuals who are judged inappropriate for the study by the principal.

Study & Design

• Study Type: Interventional
• Study Design: Not specified